Thanks to the brilliant moms on the asthma-parents email list for this one:
Warnings for Asthma Drugs Sought
ReutersSaturday, November 19, 2005; Page A08
U.S. regulators yesterday asked the makers of three popular asthma medications to add warnings to their labels stating that the drugs could increase the chances of severe asthma episodes that could result in death.
The warnings involve long-acting bronchodilator medicines Advair and Serevent, made by GlaxoSmithKline, and Foradil from Novartis AG. Patients use them daily to relax bronchial muscles and prevent asthma attacks.
In a public health advisory issued on its Web site, the Food and Drug Administration said drugs in the class known as long-acting beta 2-adrenergic agonists should only be used after other medicines fail to control asthma.
Read the whole thing...
No comments:
Post a Comment